TREATMENT READING
Mycosis Fungoides and Other Cutaneous T-Cell Lymphomas
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
2 studies cited in this topic · see design and results →
Explore 17 related disease and treatment settings → · Source-derived catalogue; clinical review pending.
Certain factors affect prognosis (chance of recovery) and treatment options.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Mycosis fungoides and Sézary syndrome can recur (come back) after they have been treated.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Treatment Option Overview
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Key Points
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
There are different types of treatment for patients with mycosis fungoides and cancer.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Seven types of standard treatment are used:
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Photodynamic therapy
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Radiation therapy
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Chemotherapy
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Other drug therapy
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Immunotherapy
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Targeted therapy
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
High-dose chemotherapy and radiation therapy with stem cell transplant
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
New types of treatment are being tested in clinical trials.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Immune checkpoint inhibitor therapy
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Treatment for mycosis fungoides and Sézary syndrome may cause side effects.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Patients may want to think about taking part in a clinical trial.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Patients can enter clinical trials before, during, or after starting their cancer treatment.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Follow-up tests may be needed.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Treatment of Stage I and Stage II Mycosis Fungoides
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Treatment of Stage III and Stage IV Mycosis Fungoides (Including Sézary Syndrome)
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Treatment Recurrent Mycosis Fungoides (Including and Sézary Syndrome)
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle